» Articles » PMID: 36483930

Associations of Phthalates with NAFLD and Liver Fibrosis: A Nationally Representative Cross-sectional Study from NHANES 2017 to 2018

Overview
Journal Front Nutr
Date 2022 Dec 9
PMID 36483930
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Although phthalates are common environmental pollutants, few studies have focused on the relationship of phthalates exposure with non-alcoholic fatty liver disease (NAFLD) or liver fibrosis, and especially, the alternative phthalates have been questioned in recent years about whether they are better choices. Thus, this study aimed to explore the associations of exposure to major phthalates or alternative phthalates with NAFLD and liver fibrosis.

Methods: Data of 1450 adults from the National Health and Nutrition Examination Survey (NHANES) 2017-2018 were collected. The urinary metabolite concentrations of di-2-ethylhexyl phthalate (DEHP), diisononyl phthalate (DINP) and diisodecyl phthalate (DIDP) were detected. Controlled attenuation parameter (CAP) and median liver stiffness measurement (LSM) were acquired for quantitative diagnosis of NAFLD and liver fibrosis by vibration-controlled transient elastography. Multivariate logistic regression analysis and linear regression analysis were performed to examine the associations between phthalates and NAFLD and liver fibrosis.

Results: After adjustment of the potential factors, the prevalence of NAFLD was significantly elevated among those in the fourth quartile of mono-(2-ethyl-5-carboxypentyl) phthalate (OR, 95%CI = 2.719, 1.296, 5.700, = 0.016), mono (2-ethyl-5-hydroxyhexyl) phthalate (OR, 95%CI = 2.073, 1.111, 3.867, = 0.037). No significant association was found between the alternative phthalates and NAFLD. The similar result was gained by linear regression analysis that MECPP was still significantly associated with Ln CAP (Q4 vs. Q1: β, 95%CI = 0.067, 0.017, 0.118, = 0.027). After adjustment for the same covariates, no significant association between phthalates and liver fibrosis was found in logistics regression analysis.

Conclusions: All in all, higher prevalence of NAFLD is correlated with DEHP but not DINP or DIDP in American adults. There is no significant relationship between phthalates and liver fibrosis defined as LSM ≥ 8 Kpa. Nevertheless, further research is needed to provide evidence of causality.

Citing Articles

Methyl -Butyl Ether May Be a Potential Environmental Pathogenic Factor for Nonalcoholic Fatty Liver Disease: Results from NHANES 2017-2020.

Cui F, Wang H, Guo M, Sun Y, Xin Y, Gao W Environ Health (Wash). 2025; 3(2):190-198.

PMID: 40012874 PMC: 11851211. DOI: 10.1021/envhealth.4c00140.


Association of dietary quality and mortality in the non-alcoholic fatty liver disease and advanced fibrosis populations: NHANES 2005-2018.

Huang X, Zhang X, Hao X, Wang T, Wu P, Shen L Front Nutr. 2025; 12:1507342.

PMID: 39917744 PMC: 11798782. DOI: 10.3389/fnut.2025.1507342.


Probiotics as Potential Tool to Mitigate Nucleotide Metabolism Alterations Induced by DiNP Dietary Exposure in .

Giommi C, Maradonna F, Ladisa C, Habibi H, Carnevali O Int J Mol Sci. 2024; 25(20).

PMID: 39456934 PMC: 11508264. DOI: 10.3390/ijms252011151.


Association between phthalates exposure and non-alcoholic fatty liver disease under different diagnostic criteria: a cross-sectional study based on NHANES 2017 to 2018.

Zou J, Gu Q, Gu D Front Public Health. 2024; 12:1407976.

PMID: 39386944 PMC: 11462993. DOI: 10.3389/fpubh.2024.1407976.


Association Between Urinary Phthalate Metabolites and Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.

Li X, Li Z, Ye J, Ye W Int J Chron Obstruct Pulmon Dis. 2024; 19:1421-1431.

PMID: 38948906 PMC: 11212814. DOI: 10.2147/COPD.S459435.


References
1.
Jauregui E, Lock J, Rasmussen L, Craig Z . Mono-n-Butyl Phthalate Distributes to the Mouse Ovary and Liver and Alters the Expression of Phthalate-Metabolizing Enzymes in Both Tissues. Toxicol Sci. 2021; 183(1):117-127. PMC: 8502470. DOI: 10.1093/toxsci/kfab085. View

2.
Ciardullo S, Perseghin G . Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver Int. 2021; 41(6):1290-1293. DOI: 10.1111/liv.14828. View

3.
Wan H, Wang Y, Zhang H, Zhang K, Chen Y, Chen C . Chronic lead exposure induces fatty liver disease associated with the variations of gut microbiota. Ecotoxicol Environ Saf. 2022; 232:113257. DOI: 10.1016/j.ecoenv.2022.113257. View

4.
Xu Q, Qi W, Zhang Y, Wang Q, Ding S, Han X . DNA methylation of JAK3/STAT5/PPARγ regulated the changes of lipid levels induced by di (2-ethylhexyl) phthalate and high-fat diet in adolescent rats. Environ Sci Pollut Res Int. 2020; 27(24):30232-30242. DOI: 10.1007/s11356-020-08976-x. View

5.
Chen H, Zhang W, Rui B, Yang S, Xu W, Wei W . Di(2-ethylhexyl) phthalate exacerbates non-alcoholic fatty liver in rats and its potential mechanisms. Environ Toxicol Pharmacol. 2016; 42:38-44. DOI: 10.1016/j.etap.2015.12.016. View